ISAC

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Thursday, March 21, 2024

REDWOOD CITY, Calif., March 21, 2024 (GLOBE NEWSWIRE) --  Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.

Key Points: 
  • –   Cash balance of $128.6 million as of December 31, 2023, anticipated to fund key milestones through late 2025
    REDWOOD CITY, Calif., March 21, 2024 (GLOBE NEWSWIRE) --  Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.
  • “We made substantial progress advancing our two proprietary clinical-stage development programs in 2023,” said Randall Schatzman, Ph.D., Chief Executive Officer.
  • “We have now administered BDC-1001, which we have renamed trastuzumab imbotolimod, to patients in all five of the Phase 2 cohorts.
  • BDC-3042 also continues to advance, and has now entered the fourth dose escalation cohort without a dose-limiting toxicity.

Health-ISAC Publishes 2023 Annual Report

Retrieved on: 
Tuesday, March 19, 2024

ORMOND BEACH, Fla., March 19, 2024 (GLOBE NEWSWIRE) -- Health-ISAC (Health Information Sharing and Analysis Center), a non-profit, member-driven community for global health sector resilience, released its 2023 Annual Report.

Key Points: 
  • ORMOND BEACH, Fla., March 19, 2024 (GLOBE NEWSWIRE) -- Health-ISAC (Health Information Sharing and Analysis Center), a non-profit, member-driven community for global health sector resilience, released its 2023 Annual Report.
  • The report showcases the activities Health-ISAC undertook during the year to help ensure the resilience of the sector.
  • "The 2023 Annual Report reflects the commitment to fulfilling our mission of advancing physical and cyber resilience in the global health industry," says Denise Anderson, President and CEO, Health-ISAC.
  • Access the 2023 Annual Report here: https://h-isac.org/health-isac-publishes-2023-annual-report/.

At MWC, InterDigital to Showcase Innovation Empowering Connected Experiences ‘At Work, At Rest, and At Play’

Retrieved on: 
Monday, February 19, 2024

“InterDigital innovation creates value through the tools we create and through the experiences they enable,” said Rajesh Pankaj, EVP and CTO at InterDigital.

Key Points: 
  • “InterDigital innovation creates value through the tools we create and through the experiences they enable,” said Rajesh Pankaj, EVP and CTO at InterDigital.
  • InterDigital is a long-time contributor to MPEG Immersive Standards, including Scene Description, V3C codecs alongside partner Philips, and newer haptics codecs to enable seamless, immersive experiences.
  • Elsewhere at MWC, InterDigital will lead stage presentations and showcase at partner booths to further amplify the impact of our research and innovation.
  • At the Keysight booth located at Hall 5 Stand 5E12, InterDigital and Keysight will together showcase a 144 GHz testbed utilizing an AI-enabled air interface.

Solutions for Testing Wireless, IP, Fiber Optics, Analog, and TDM Networks

Retrieved on: 
Monday, January 22, 2024

“GL Communications Inc. is a leading test and measurement equipment manufacturer for Wireless, IP, Fiber Optic, Analog and TDM networks.

Key Points: 
  • “GL Communications Inc. is a leading test and measurement equipment manufacturer for Wireless, IP, Fiber Optic, Analog and TDM networks.
  • GL also offers consulting services to design, implement, verify, and inspect communications systems including wireless, IP, satellite, fiber optic, digital, and microwave networks.
  • GL offers multi-functional Ethernet testers to test individual devices such as cables, switches, routers, as well as end-to-end Ethernet/IP networks.
  • The test tools operate at wirespeed (1/10/25/40/50/100 Gbps) and offer bit error rate testing, RFC 2544, ITU-T Y.1564 and RFC 6349 based TCP testing.

5G Americas Explores 3GPP's Release 18 and Beyond in 5G-Advanced

Retrieved on: 
Wednesday, January 10, 2024

Today, 5G Americas, the voice of 5G and beyond in the Americas, has released a white paper titled ‘ 3GPP Technology Trends ’ which provides a detailed overview of the 3rd Generation Partnership Project (3GPP) and its journey towards 5G-Advanced that begins with Release 18 (NR Rel-18).

Key Points: 
  • Today, 5G Americas, the voice of 5G and beyond in the Americas, has released a white paper titled ‘ 3GPP Technology Trends ’ which provides a detailed overview of the 3rd Generation Partnership Project (3GPP) and its journey towards 5G-Advanced that begins with Release 18 (NR Rel-18).
  • Chris Pearson, President, 5G Americas said, "The enhancements brought forth in 3GPP Release 17, such as improved uplink coverage, precision in positioning, and robust power-saving features, signify more than just technological advancements.
  • They represent a leap towards a future where connectivity is both ubiquitous and seamlessly integrated into our daily lives."
  • The document underscores pivotal progressions in NR Rel-17, emphasizing their transformative effects on cellular networks and the wider technology arena.

Industrial Defender Joins the E-ISAC Vendor Affiliate Program

Retrieved on: 
Tuesday, January 9, 2024

FOXBOROUGH, Mass., Jan. 9, 2024 /PRNewswire/ -- Industrial Defender, a pioneering leader in operational technology (OT) security and compliance, is proud to announce its new affiliation with the Electricity Information Sharing and Analysis Center (E-ISAC). Joining the E-ISAC's Vendor Affiliate Program as a Gold level member aligns with Industrial Defender's mission to bolster cybersecurity and compliance in the electricity sector across North America.

Key Points: 
  • Joining the E-ISAC's Vendor Affiliate Program as a Gold level member aligns with Industrial Defender's mission to bolster cybersecurity and compliance in the electricity sector across North America.
  • "Our partnership with E-ISAC represents an important milestone in our collaborative efforts with stakeholders in the electricity industry," said Jay Williams, CEO of Industrial Defender.
  • As a Gold level member of the E-ISAC Vendor Affiliate Program, Industrial Defender brings to the table its vast experience and expertise in OT asset management and compliance with the North American Electric Reliability Corporation (NERC) Critical Infrastructure Protection (NERC CIP) standards.
  • Industrial Defender's participation in the E-ISAC's Vendor Affiliate Program signals a strong commitment to enhancing information sharing and fostering collaboration between the electricity industry and vendor community.

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®

Retrieved on: 
Tuesday, December 5, 2023

The trial will treat patients with HER2-positive metastatic breast cancer previously treated with trastuzumab deruxtecan (Enhertu®).

Key Points: 
  • The trial will treat patients with HER2-positive metastatic breast cancer previously treated with trastuzumab deruxtecan (Enhertu®).
  • “Patients with HER2-positive breast cancer who progress after Enhertu have few therapeutic options,” said Edith A. Perez, M.D., Chief Medical Officer of Bolt Biotherapeutics.
  • “BDC-1001 has a unique mechanism of action compared to available agents, mobilizing the patient’s immune system to fight cancer.
  • Title: Phase 2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 +/- pertuzumab in patients with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab deruxtecan.

InterDigital’s Alain Mourad Elected Chair of New ETSI Industry Specification Group on Integrated Sensing and Communications (ISAC)

Retrieved on: 
Tuesday, November 21, 2023

WILMINGTON, Del., Nov. 21, 2023 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, today announced that Dr. Alain Mourad, Head of InterDigital’s Wireless Lab Europe, has been elected Chair of the ETSI’s newly developed Industry Specification Group (ISG) on Integrated Sensing and Communication (ISAC).

Key Points: 
  • WILMINGTON, Del., Nov. 21, 2023 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, today announced that Dr. Alain Mourad, Head of InterDigital’s Wireless Lab Europe, has been elected Chair of the ETSI’s newly developed Industry Specification Group (ISG) on Integrated Sensing and Communication (ISAC).
  • This enables the network to collect data on a plethora of device and object features, including range, velocity, position, orientation, size, shape, image, materials, and more.
  • “I’m delighted to lead the ISAC ISG for its inaugural two-year release.
  • “Alain’s strong leadership as the chair of the ETSI ISG on ISAC will provide a bedrock for enhanced capabilities and new use cases to explore in 6G,” said Rajesh Pankaj, Chief Technology Officer, InterDigital.

Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Thursday, November 9, 2023

Collaboration Revenue – Collaboration revenue was $2.5 million for the quarter ended September 30, 2023, compared to $2.1 million for the same quarter in 2022.

Key Points: 
  • Collaboration Revenue – Collaboration revenue was $2.5 million for the quarter ended September 30, 2023, compared to $2.1 million for the same quarter in 2022.
  • Research and Development (R&D) Expenses – R&D expenses were $15.0 million for the quarter ended September 30, 2023, compared to $19.0 million for the same quarter in 2022.
  • General and Administrative (G&A) Expenses – G&A expenses were $5.8 million for the quarter ended September 30, 2023, compared to $5.5 million for the same quarter in 2022.
  • Loss from Operations – Loss from operations was $18.2 million for the quarter ended September 30, 2023, compared to $22.3 million for the same quarter in 2022.

KBRA Assigns Rating to AeBe ISA Ltd.

Retrieved on: 
Tuesday, November 21, 2023

KBRA assigns an A- insurance financial strength rating (IFSR) to AeBe ISA Ltd (AeBe), a Class E licensed Bermuda-based reinsurer that has GAAP total assets of approximately $4.4 billion as of June 30, 2023.

Key Points: 
  • KBRA assigns an A- insurance financial strength rating (IFSR) to AeBe ISA Ltd (AeBe), a Class E licensed Bermuda-based reinsurer that has GAAP total assets of approximately $4.4 billion as of June 30, 2023.
  • KBRA believes that the ISAC structure provides a robust corporate framework as well as operational flexibility to AeBe as the company onboards future business.
  • As AeBe executes its business plan, KBRA expects this ratio to decrease but remain strong over the medium term.
  • Additional information regarding KBRA policies, methodologies, rating scales and disclosures are available at www.kbra.com .